Work

FCgamma Receptor Polymorphisms Do Not Influence the Outcome of Treatment with Rituximab Followed by Active Immunotherapy with Mitumprotimut-T (FavId®, Id-KLH).

Year: 2007
Type: article
Source: Blood
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W2567184590
FWCI: 0.224
Cites:
Cited by: 1
Related to: 10